• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2型糖尿病会增加非酒精性脂肪性肝病患者患肝细胞癌的风险吗?一项系统评价。

Does Type 2 Diabetes Increase the Risk of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease Patients? A Systematic Review.

作者信息

Venugopal Sathish, Dhanoa Ravneet K, Selvamani Tharun Yadhav, Shoukrie Shoukrie I, Zahra Anam, Malla Jyothirmai, Selvaraj Ramaneshwar, Hamouda Ranim K, Mohammed Lubna

机构信息

Neurology, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.

Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.

出版信息

Cureus. 2023 Mar 13;15(3):e36079. doi: 10.7759/cureus.36079. eCollection 2023 Mar.

DOI:10.7759/cureus.36079
PMID:37065332
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10101195/
Abstract

Diabetes is associated with different types of cancers of which hepatocellular carcinoma (HCC) is one among them. In a study comparing patients with diabetes to those who do not have diabetes, it was evident that the risk of HCC is found to increase two-fold in diabetic than that in non-diabetic patients. It is clear that carcinogenesis is advanced due to diabetes in the liver by a variety of mechanisms. We searched PubMed and Google Scholar for articles from 2010 to 2021 that have an association between diabetes, nonalcoholic fatty liver disease (NAFLD), and HCC. For the development of HCC, diabetes is likely related at both the molecular and epidemiological levels. Both diabetes mellitus and hepatic malignancy have the worst impact on mankind socioeconomically. There is a significant relationship between diabetes and HCC independent of alcohol consumption and viral hepatitis. It is noteworthy that not only the elderly but also people of all age groups should monitor their hemoglobin A1C levels. Diet restriction and lifestyle modification can reduce the risk of complications like HCC; the increased physical activity itself can have a major influence on health and can manage comorbidities like diabetes, NAFLD, and HCC.

摘要

糖尿病与不同类型的癌症相关,肝细胞癌(HCC)是其中之一。在一项将糖尿病患者与非糖尿病患者进行比较的研究中,明显发现糖尿病患者患HCC的风险是非糖尿病患者的两倍。显然,糖尿病通过多种机制促进了肝脏的致癌作用。我们在PubMed和谷歌学术上搜索了2010年至2021年期间有关糖尿病、非酒精性脂肪性肝病(NAFLD)和HCC之间关联的文章。对于HCC的发生发展,糖尿病可能在分子和流行病学层面都存在关联。糖尿病和肝脏恶性肿瘤对人类社会经济都有最严重的影响。糖尿病与HCC之间存在显著关联,且与饮酒和病毒性肝炎无关。值得注意的是,不仅老年人,所有年龄段的人都应监测其糖化血红蛋白水平。饮食限制和生活方式改变可以降低HCC等并发症的风险;增加体育活动本身就能对健康产生重大影响,并能控制糖尿病、NAFLD和HCC等合并症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee6d/10101195/88cdffb9b6cd/cureus-0015-00000036079-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee6d/10101195/22569ed45469/cureus-0015-00000036079-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee6d/10101195/a30ee65cebe3/cureus-0015-00000036079-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee6d/10101195/88cdffb9b6cd/cureus-0015-00000036079-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee6d/10101195/22569ed45469/cureus-0015-00000036079-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee6d/10101195/a30ee65cebe3/cureus-0015-00000036079-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee6d/10101195/88cdffb9b6cd/cureus-0015-00000036079-i03.jpg

相似文献

1
Does Type 2 Diabetes Increase the Risk of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease Patients? A Systematic Review.2型糖尿病会增加非酒精性脂肪性肝病患者患肝细胞癌的风险吗?一项系统评价。
Cureus. 2023 Mar 13;15(3):e36079. doi: 10.7759/cureus.36079. eCollection 2023 Mar.
2
Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.非酒精性脂肪性肝病、代谢风险因素与肝细胞癌:一个悬而未决的问题。
World J Gastroenterol. 2015 Apr 14;21(14):4103-10. doi: 10.3748/wjg.v21.i14.4103.
3
Screening and interventions to prevent nonalcoholic fatty liver disease/nonalcoholic steatohepatitis-associated hepatocellular carcinoma.筛查和干预措施以预防非酒精性脂肪性肝病/非酒精性脂肪性肝炎相关肝细胞癌。
World J Gastroenterol. 2023 Jan 14;29(2):286-309. doi: 10.3748/wjg.v29.i2.286.
4
Nonalcoholic fatty liver disease and hepatocellular carcinoma.非酒精性脂肪性肝病与肝细胞癌
Metabolism. 2016 Aug;65(8):1151-60. doi: 10.1016/j.metabol.2016.01.010. Epub 2016 Jan 23.
5
Increased prevalence but decreased survival of nonviral hepatocellular carcinoma compared to viral hepatocellular carcinoma in recent ten years.近十年来,非病毒性肝细胞癌的发病率增加,但生存率却低于病毒性肝细胞癌。
Sci Rep. 2024 Apr 20;14(1):9068. doi: 10.1038/s41598-024-59668-2.
6
Differentiation of clinical patterns and survival outcomes of hepatocellular carcinoma on hepatitis B and nonalcoholic fatty liver disease.乙型肝炎和非酒精性脂肪性肝病患者肝癌的临床特征和生存结局的差异。
J Chin Med Assoc. 2021 Jun 1;84(6):606-613. doi: 10.1097/JCMA.0000000000000530.
7
Association of metabolic traits with occurrence of nonalcoholic fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis of longitudinal cohort studies.代谢特征与非酒精性脂肪性肝病相关肝细胞癌发生的关系:纵向队列研究的系统评价和荟萃分析。
Saudi J Gastroenterol. 2022 Mar-Apr;28(2):92-100. doi: 10.4103/sjg.sjg_260_21.
8
Diabetes and Risk of Hepatocellular Carcinoma in Cirrhosis Patients with Nonalcoholic Fatty Liver Disease.糖尿病与非酒精性脂肪性肝病合并肝硬化患者肝细胞癌风险的关系。
Gut Liver. 2023 Jan 15;17(1):24-33. doi: 10.5009/gnl220357. Epub 2022 Dec 19.
9
The Current View of Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma.非酒精性脂肪性肝病相关肝细胞癌的当前观点
Cancers (Basel). 2021 Jan 29;13(3):516. doi: 10.3390/cancers13030516.
10
Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease, alcoholic liver disease, and chronic liver disease of unknown etiology: report of the nationwide survey.日本非酒精性脂肪性肝病、酒精性肝病和病因不明的慢性肝病患者的肝细胞癌:全国调查报告。
J Gastroenterol. 2011 Oct;46(10):1230-7. doi: 10.1007/s00535-011-0431-9. Epub 2011 Jul 13.

引用本文的文献

1
Both Maternal High-Fat and Post-Weaning High-Carbohydrate Diets Increase Rates of Spontaneous Hepatocellular Carcinoma in Aged-Mouse Offspring.母体高脂肪和断乳后高碳水化合物饮食均可增加老年小鼠后代自发性肝细胞癌的发生率。
Nutrients. 2024 Aug 22;16(16):2805. doi: 10.3390/nu16162805.

本文引用的文献

1
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.《PRISMA 2020声明:报告系统评价的更新指南》
Syst Rev. 2021 Mar 29;10(1):89. doi: 10.1186/s13643-021-01626-4.
2
Prognostic roles of diabetes mellitus and hypertension in advanced hepatocellular carcinoma treated with sorafenib.索拉非尼治疗晚期肝细胞癌中糖尿病和高血压的预后作用。
PLoS One. 2020 Dec 31;15(12):e0244293. doi: 10.1371/journal.pone.0244293. eCollection 2020.
3
Diabetes Is Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Cirrhosis From Nonalcoholic Fatty Liver Disease.
糖尿病与非酒精性脂肪性肝病相关肝硬化患者肝细胞癌风险增加相关。
Hepatology. 2020 Mar;71(3):907-916. doi: 10.1002/hep.30858. Epub 2019 Oct 21.
4
Models estimating risk of hepatocellular carcinoma in patients with alcohol or NAFLD-related cirrhosis for risk stratification.用于风险分层的酒精或非酒精性脂肪性肝病相关肝硬化患者肝细胞癌风险的预测模型。
J Hepatol. 2019 Sep;71(3):523-533. doi: 10.1016/j.jhep.2019.05.008. Epub 2019 May 28.
5
Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts.在四个欧洲队列中对诊断为非酒精性脂肪性肝病的成年人进行的真实世界研究:肝硬化和肝细胞癌诊断的风险和临床预测因子。
BMC Med. 2019 May 20;17(1):95. doi: 10.1186/s12916-019-1321-x.
6
Hepatocellular carcinoma is the most common liver-related complication in patients with histopathologically-confirmed NAFLD in Japan.在日本,肝细胞癌是组织病理学确诊的非酒精性脂肪性肝病患者最常见的肝脏相关并发症。
BMC Gastroenterol. 2018 Nov 6;18(1):165. doi: 10.1186/s12876-018-0900-1.
7
Type 2 diabetes mellitus and non-alcoholic fatty liver disease: a systematic review and meta-analysis.2型糖尿病与非酒精性脂肪性肝病:一项系统评价与荟萃分析
Gastroenterol Hepatol Bed Bench. 2017 Winter;10(Suppl1):S1-S7.
8
Diabetes Mellitus and Risk of Hepatocellular Carcinoma.糖尿病与肝细胞癌风险。
Biomed Res Int. 2017;2017:5202684. doi: 10.1155/2017/5202684. Epub 2017 Dec 12.
9
Hepatocellular carcinoma: a clinicopathological study of 64 cases.肝细胞癌:64例临床病理研究
Pan Afr Med J. 2017 May 16;27:41. doi: 10.11604/pamj.2017.27.41.9584. eCollection 2017.
10
Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease.非酒精性脂肪性肝病患者的肝细胞癌
World J Gastroenterol. 2016 Oct 7;22(37):8294-8303. doi: 10.3748/wjg.v22.i37.8294.